This bill is aimed at keeping people from losing access to their doctors, specialists, and prescription drug coverage in Medicare and individual health plans. It would likely address coverage disruptions such as narrow networks, formulary changes, or administrative barriers that can force patients to switch providers or medicines. The main people affected are Medicare beneficiaries and people who buy coverage on the individual market, along with the doctors and pharmacies that serve them. Its practical goal is continuity of care: preserving access to the clinicians and drugs patients already rely on.
What This Bill Does
- Targets Medicare and individual market health plans.
- Aims to preserve access to health care providers patients already use.
- Seeks to protect prescription drug coverage continuity.
- Would reduce the chance of losing a doctor or medication because of coverage changes.
Who This Bill Affects
If you are on Medicare or buy insurance on the individual market, this bill would be aimed at making it easier to keep the doctors and prescription drugs you already use. That could reduce the risk of surprise coverage changes, network disruptions, or medication switches that can interrupt ongoing treatment. For patients with chronic conditions or specialty care needs, the effect could be meaningful because continuity of care often matters as much as the coverage itself.
See how this bill affects you — sign in for a personalized analysisWho Supports & Opposes This
- Medicare beneficiaries They benefit when they can keep seeing trusted doctors and stay on the medications that are already working. Stable coverage can be especially important for older adults with multiple conditions and frequent specialist care.
- People buying insurance on the individual market They often have fewer plan choices and can be hit hard when networks or formularies change. Protections that preserve access can make coverage more reliable and reduce unexpected disruptions.
- Primary care doctors and specialists Continuity rules can help patients stay with the clinicians who know their medical history. That can improve treatment adherence and reduce delays caused by referrals, prior authorization disputes, or switching plans.
- Health insurers They may argue that stronger access rules limit their ability to design lower-cost networks and drug formularies. Insurers often say these tools are necessary to keep premiums in check and manage spending.
- Employers and premium-sensitive consumers Some will worry that preserving broader provider and drug access could increase plan costs over time. Higher costs can be passed through in the form of higher premiums, deductibles, or copays.
- Pharmacy benefit managers and cost-control advocates They may contend that less flexibility in formulary design weakens leverage in negotiations with drug manufacturers. That could make it harder to secure discounts or steer patients to more cost-effective therapies.
Key Implications
-
““preserve patient access to health care providers””
This indicates a focus on keeping existing doctor-patient relationships intact, which can matter most for people in ongoing treatment or managing chronic disease.
-
““prescription drug coverage””
The bill is aimed at keeping medications covered rather than allowing abrupt formulary exclusions or sudden coverage changes that force patients to switch drugs.
-
““under Medicare and individual market plans””
The scope reaches both a large public program for older and disabled Americans and private coverage sold to individuals, so the protections would apply across two major coverage channels.
Official Source & Bill Facts
BillBoard checks this page against public Congress.gov metadata, then adds plain-English analysis where available.
- Bill
- S 4924
- Congress
- 119th Congress
- Official title
- A bill to preserve patient access to health care providers and prescription drug coverage under Medicare and individual market plans.
- Policy area
- Healthcare
- Latest action
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (June 24, 2026)
- Last updated
- June 25, 2026
Latest Status
June 24, 2026
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Related Bills
Take Action
Get more from BillBoard
Free tools to understand, respond to, and track this bill.
Ask AI about this billData sourced from api.congress.gov.